EXICURE, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
2430 N. HALSTED ST., CHICAGO, IL, 60614
Mailing Address
2430 N. HALSTED ST., CHICAGO, IL, 60614
Phone
847-673-1707
Fiscal Year End
1231
EIN
815333008
Financial Overview
FY2025
$10.12M
Total Liabilities
$-0.79
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 10-K Annual financial report | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| 8-K Current report of material events | February 17, 2026 | View on SEC |
| 8-K Current report of material events | February 10, 2026 | View on SEC |
| 8-K Current report of material events | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
Annual Reports
10-K
March 25, 2026
- Transitioned from a biotech firm to a public shell entity seeking a reverse merger.
- Successfully liquidated remaining intellectual property and lab equipment to generate liquidity.
Material Events
8-K
Financial Distress
March 25, 2026
High Impact
- Active pursuit of a merger or acquisition as the company's sole path forward
- Potential for a 'reverse merger' utilizing the company's existing public listing and patents
8-K
Leadership Change
February 17, 2026
High Impact
- New leadership appointed through Innocircle Advisors Inc., suggesting specialized turnaround expertise.
- Jung Soo Kim (new CEO & President) brings over 20 years in corporate strategy, M&A, and business reorganization.
8-K
Leadership Change
February 10, 2026
High Impact
- New board members Jung Kyu Ham, Jung Soo Kim, and Gyeung Seog Cheon appointed to provide fresh perspectives and oversight.
- Company stated resignations did not stem from disagreements, suggesting a planned transition.
Insider Trading
STRONG SELL
2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.